Clinical Trial

A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

Study acronym: CYCLONE 2
Active, Not Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednisone per local regulation.
Protocol Amendment History 1 change
minor Completion pushed: 2026-06 -> 2026-12 2026-08-08
Trial Details
NCT Number NCT03706365
Lead Sponsor Eli Lilly and Company
Conditions Prostate Cancer
Enrollment 393 participants
Start Date 2018-11-26
Primary Completion 2024-01-02 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-07